• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物标志物的变化聚焦于神经白塞病患者疾病进程或治疗方面的差异。

Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease.

作者信息

Hirohata Shunsei, Kikuchi Hirotoshi

机构信息

Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan.

出版信息

Intern Med. 2012;51(24):3359-65. doi: 10.2169/internalmedicine.51.8583. Epub 2012 Dec 15.

DOI:10.2169/internalmedicine.51.8583
PMID:23257520
Abstract

OBJECTIVE

Neurological manifestations of Behçet's disease (NB) are serious complications. However, their pathogenesis remains unclear. The current study examined the levels of proinflammatory cytokines, including IL-1β, IL-6, IL-8 and TNF-α, in cerebrospinal fluid (CSF).

METHODS

CSF cytokines were measured using an enzyme-linked immunosorbent assay. CSF was obtained from 17 patients with acute NB, 19 patients with chronic progressive NB and 20 patients with non-inflammatory neurological diseases, including cerebrovascular disease, cervical spondylosis and degenerative diseases.

RESULTS

CSF total cell counts and polymorph nuclear leukocyte counts were significantly lower in the patients with chronic progressive NB than in those with acute NB. The CSF levels of IL-6 and IL-8 were markedly elevated in the NB patients compared with those measured in the control patients. There were no significant differences in the CSF levels of IL-6 and IL-8 between the patients with acute NB and those with chronic progressive NB. In contrast, there were no significant differences in the CSF levels of IL-1β and TNF-α among the control, acute NB and chronic progressive NB patients. Consistently, the CSF levels of IL-6 and IL-8 were significantly decreased following successful treatment in both acute NB and chronic progressive NB patients, whereas the CSF levels of IL-1β and TNF-α were not changed significantly. Of note, the CSF levels of IL-6 were significantly correlated with the CSF levels of IL-8 in the patients with acute NB (r =0.7647, p =0.0003) but not in the patients with chronic progressive NB (r =0.1343, p =0.5835).

CONCLUSION

These results indicate that CSF IL-6 and IL-8 play important roles in the pathogenesis of NB. However, the data also suggest that the mechanisms underlying the elevation of CSF IL-6 and IL-8 might be different in patients with acute NB and those with chronic progressive NB.

摘要

目的

白塞病的神经表现(NB)是严重的并发症。然而,其发病机制仍不清楚。本研究检测了脑脊液(CSF)中促炎细胞因子的水平,包括白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)和肿瘤坏死因子-α(TNF-α)。

方法

采用酶联免疫吸附测定法检测脑脊液细胞因子。从17例急性NB患者、19例慢性进行性NB患者和20例非炎性神经疾病患者(包括脑血管疾病、颈椎病和退行性疾病)中获取脑脊液。

结果

慢性进行性NB患者的脑脊液总细胞计数和多形核白细胞计数显著低于急性NB患者。与对照组患者相比,NB患者脑脊液中IL-6和IL-8水平显著升高。急性NB患者和慢性进行性NB患者脑脊液中IL-6和IL-8水平无显著差异。相比之下,对照组、急性NB患者和慢性进行性NB患者脑脊液中IL-1β和TNF-α水平无显著差异。同样,急性NB和慢性进行性NB患者成功治疗后脑脊液中IL-6和IL-8水平显著降低,而脑脊液中IL-1β和TNF-α水平无显著变化。值得注意的是,急性NB患者脑脊液中IL-6水平与IL-8水平显著相关(r =0.7647,p =0.0003),而慢性进行性NB患者则无相关性(r =0.1343,p =0.5835)。

结论

这些结果表明脑脊液IL-6和IL-8在NB发病机制中起重要作用。然而,数据也表明急性NB患者和慢性进行性NB患者脑脊液中IL-6和IL-8升高的机制可能不同。

相似文献

1
Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease.生物标志物的变化聚焦于神经白塞病患者疾病进程或治疗方面的差异。
Intern Med. 2012;51(24):3359-65. doi: 10.2169/internalmedicine.51.8583. Epub 2012 Dec 15.
2
Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.进行性神经白塞病综合征中的脑脊液白细胞介素-6
Clin Immunol Immunopathol. 1997 Jan;82(1):12-7. doi: 10.1006/clin.1996.4268.
3
Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases.与多发性硬化症及其他神经系统疾病相比,神经白塞病中的细胞因子和趋化因子
J Neuroimmunol. 2003 Dec;145(1-2):127-34. doi: 10.1016/j.jneuroim.2003.08.040.
4
Quantitative analysis of brainstem atrophy on magnetic resonance imaging in chronic progressive neuro-Behçet's disease.慢性进行性神经白塞病脑干萎缩的磁共振成像定量分析
J Neurol Sci. 2014 Feb 15;337(1-2):80-5. doi: 10.1016/j.jns.2013.11.020. Epub 2013 Nov 21.
5
Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome.神经白塞病中的白细胞介素-6:与疾病亚型及长期预后的关联
Cytokine. 2008 Dec;44(3):373-6. doi: 10.1016/j.cyto.2008.10.007. Epub 2008 Nov 17.
6
[Chronic Progressive Neuro-Behçet's Disease].[慢性进行性神经白塞病]
Brain Nerve. 2021 May;73(5):568-575. doi: 10.11477/mf.1416201800.
7
Cerebrospinal fluid beta(2)-microglobulin in neuro-Behçet's syndrome.神经白塞病中的脑脊液β2-微球蛋白
J Neurol Sci. 2000 Oct 1;179(S 1-2):132-9. doi: 10.1016/s0022-510x(00)00403-2.
8
CSF levels of cytokines in neuro-Behçet's disease.神经白塞病中脑脊液细胞因子水平
Clin Neurol Neurosurg. 2009 Jul;111(6):507-10. doi: 10.1016/j.clineuro.2009.02.001. Epub 2009 Mar 19.
9
Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.神经白塞病患者脑脊液中白细胞介素-37水平降低与炎性细胞因子呈负相关。
Iran J Immunol. 2019 Dec;16(4):299-310. doi: 10.22034/IJI.2019.80281.
10
Effect of infliximab in progressive neuro-Behçet's syndrome.英夫利昔单抗对进行性神经白塞病的疗效
J Neurol Sci. 2008 Sep 15;272(1-2):99-105. doi: 10.1016/j.jns.2008.05.002. Epub 2008 Jun 11.

引用本文的文献

1
Neuro-Behçet's disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis.神经白塞病:临床诊断、生物标志物及免疫发病机制的最新进展
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae123.
2
Real-World Safety and Effectiveness of Infliximab in 255 Patients with Intestinal, Neurological, and Vascular Behçet's Disease: A Post-Marketing Surveillance.255 例肠病、神经病和血管型贝赫切特病患者使用英夫利昔单抗的真实世界安全性和有效性:一项上市后监测。
Adv Ther. 2024 Dec;41(12):4476-4497. doi: 10.1007/s12325-024-02993-9. Epub 2024 Oct 16.
3
Acute paracetamol toxicity-induced inflammatory and oxidative effects are relieved by Aleppo galls: a novel experimental study.
阿月浑子五倍子可缓解对乙酰氨基酚急性毒性诱导的炎症和氧化作用:一项新的实验研究。
Int J Physiol Pathophysiol Pharmacol. 2023 Feb 15;15(1):1-11. eCollection 2023.
4
Chemokines and chemokine receptors in Behçet's disease.贝赫切特病中的趋化因子和趋化因子受体。
Front Immunol. 2023 Jan 18;14:1109147. doi: 10.3389/fimmu.2023.1109147. eCollection 2023.
5
Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.脑脊液中T-bet/GATA-3和ROR-γt/Foxp3比值升高作为确诊神经白塞病的潜在标准
J Clin Med. 2022 Jul 29;11(15):4415. doi: 10.3390/jcm11154415.
6
Differential Gene Expression Patterns in Blood and Cerebrospinal Fluid of Multiple Sclerosis and Neuro-Behçet Disease.多发性硬化症和神经白塞病血液及脑脊液中的差异基因表达模式
Front Genet. 2021 Feb 26;12:638236. doi: 10.3389/fgene.2021.638236. eCollection 2021.
7
Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet's syndrome: case series and literature review.托珠单抗治疗重症难治性实质性神经白塞病:病例系列及文献综述
Ther Adv Musculoskelet Dis. 2020 Nov 16;12:1759720X20971908. doi: 10.1177/1759720X20971908. eCollection 2020.
8
T-cell Lymphoma Presenting Neutrophilic Inflammation in the Cerebrospinal Fluid.脑脊液中出现嗜中性粒细胞炎症的T细胞淋巴瘤
Intern Med. 2020 Feb 15;59(4):573-576. doi: 10.2169/internalmedicine.3093-19. Epub 2019 Oct 7.
9
Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis.急性和慢性进展性实质型神经白塞病的临床特征差异:荟萃分析。
Sci Rep. 2017 Aug 31;7(1):10196. doi: 10.1038/s41598-017-09938-z.
10
New approaches to divorce with children: A problem of public health.带子女离婚的新问题:一个公共卫生问题。
Health Psychol Open. 2016 Nov 15;3(2):2055102916678105. doi: 10.1177/2055102916678105. eCollection 2016 Jul.